Page last updated: 2024-08-17

medroxyprogesterone acetate and Fibroid

medroxyprogesterone acetate has been researched along with Fibroid in 41 studies

Research

Studies (41)

TimeframeStudies, this research(%)All Research%
pre-19902 (4.88)18.7374
1990's22 (53.66)18.2507
2000's7 (17.07)29.6817
2010's8 (19.51)24.3611
2020's2 (4.88)2.80

Authors

AuthorsStudies
Baird, DD; Cooper, TE; Harmon, QE; Patchel, SA; Umbach, DM; Zhao, S1
Lumbiganon, P; Pattanittum, P; Sangkomkamhang, US1
Chiang, W; Hsia, SM; Lin, PH; Shih, CK; Yen, YT1
Laopaiboon, M; Lumbiganon, P; Mol, BW; Sangkomkamhang, US1
McLaren, JS; Morris, EP; Rymer, J; Simpson, PD1
Baird, DD; Harmon, QE1
Martínez-Uribe, A; Olvera-Maldonado, AJ; Rendón-Macías, ME; Sangines-Martínez, A1
Britten, J; Catherino, WH; Cox, J; Malik, M; Patel, A1
Abraham, T; Arian, SE; Bartels, CB; Cayton, KC; Chuong, FS; Holthouser, K; Segars, JH1
Bristow, RE; Gu, M; Kratz, KG; Santillan, A1
Baird, DD; Davis, B; Garrett, TA; Laughlin, SK; Peddada, SD; Semelka, RC1
Chegini, N; Ma, C; Tang, XM; Williams, RS1
Fletcher, H; Johnson, N; Reid, M1
Bagratee, JS; Moodley, J; Venkatachalam, S1
Honma, H; Komura, H; Mizutani, T; Nakamuro, K; Sugihara, A; Terada, N1
Jestila, KJ; Scialli, AR1
Cartmell, L; Siegle, JC1
Ishimaru, T; Masuzaki, H; Samejima, T1
Kida, H; Minaguchi, H; Saji, M; Sakakibara, H; Taga, M1
Andersen, J; Barbieri, RL; Brink, PR; Chumas, JC; Eng, CL; Grine, E; Zhao, K1
Colacurci, N; De Placido, G; Locci, M; Montemagno, U; Zullo, F1
Cohen, JD; Robins, HI1
Bradshaw, KD; Breslau, NA; Byrd, W; Carr, BR; Marshburn, PB; Roark, M; Steinkampf, MP; Weatherall, PT1
Doğu, N; Ekici, E; Gökmen, O; Ozmen, S; Seçkin, NC; Sener, AB1
Chegini, N; Dou, Q; Kipersztok, S; Rong, H; Williams, RS1
Bäckström, AC; Granberg, S; Hirsjärvi-Lahti, T; Ylöstalo, P1
Caird, LE; Gow, SM; Hannan, WJ; Lumsden, MA; West, CP1
Bassaw, K; Gangar, K1
Altieri, P; de Aloysio, D; Penacchioni, P; Salgarello, M; Ventura, V1
Boubli, L1
D'Altorio, C; Di Biase, S; Lanzilotti, G; Orsini, G; Pinto, V1
Colleoni, R; Nappi, RE; Polatti, F; Viazzo, F1
Mastrantonio, P; Morelli, M; Noia, R; Palomba, S; Sena, T; Zullo, F1
Diedrich, K; Naether, O1
Baird, DT; Lumsden, MA; West, CP1
Blanchet, P; Friede, J; Lemay, A; Maheux, R; Pratt, X1
Brooks, PG; Serden, SP1
Abbondante, G; Aleandri, V; Benagiano, G; Elkind-Hirsch, K; Morini, A; Piccinno, F; Primiero, FM1
Barbieri, RL1
Friedman, AJ1
Barbieri, RL; Doubilet, PM; Fine, C; Friedman, AJ; Schiff, I1

Reviews

6 review(s) available for medroxyprogesterone acetate and Fibroid

ArticleYear
Progestogens or progestogen-releasing intrauterine systems for uterine fibroids (other than preoperative medical therapy).
    The Cochrane database of systematic reviews, 2020, 11-23, Volume: 11

    Topics: Adult; Antineoplastic Agents, Hormonal; Bias; Contraceptives, Oral; Desogestrel; Female; Goserelin; Humans; Intrauterine Devices, Medicated; Leiomyoma; Leuprolide; Levonorgestrel; Lynestrenol; Medroxyprogesterone Acetate; Menstruation; Middle Aged; Nandrolone; Norethindrone Acetate; Premenopause; Progestins; Randomized Controlled Trials as Topic; Tumor Burden; Uterine Neoplasms

2020
Progestogens or progestogen-releasing intrauterine systems for uterine fibroids.
    The Cochrane database of systematic reviews, 2013, Feb-28, Issue:2

    Topics: Antineoplastic Agents, Hormonal; Female; Humans; Intrauterine Devices, Medicated; Leiomyoma; Leuprolide; Levonorgestrel; Lynestrenol; Medroxyprogesterone Acetate; Menstruation; Premenopause; Progestins; Randomized Controlled Trials as Topic; Tumor Burden; Uterine Neoplasms

2013
Minimising menopausal side effects whilst treating endometriosis and fibroids.
    Post reproductive health, 2015, Volume: 21, Issue:1

    Topics: Antineoplastic Agents, Hormonal; Bone Density; Contraceptives, Oral, Combined; Delayed-Action Preparations; Endometriosis; Estrogens; Female; Gonadotropin-Releasing Hormone; Hormone Replacement Therapy; Humans; Intrauterine Devices, Medicated; Leiomyoma; Medroxyprogesterone Acetate; Menopause; Receptors, LHRH; Uterine Neoplasms

2015
An Evidence-based Approach to the Medical Management of Fibroids: A Systematic Review.
    Clinical obstetrics and gynecology, 2016, Volume: 59, Issue:1

    Topics: Androgens; Aromatase Inhibitors; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Curcumin; Delayed-Action Preparations; Drugs, Chinese Herbal; Estradiol; Estrenes; Estrogen Receptor Antagonists; Evidence-Based Medicine; Female; Fulvestrant; Gonadotropin-Releasing Hormone; Hormone Antagonists; Humans; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Medroxyprogesterone Acetate; Mifepristone; Neoadjuvant Therapy; Norpregnadienes; Oximes; Plant Extracts; Receptors, Progesterone; Selective Estrogen Receptor Modulators; Tea; Uterine Myomectomy; Uterine Neoplasms; Vitamin D; Vitamins

2016
[Drug treatment of uterine fibromas].
    Journal de gynecologie, obstetrique et biologie de la reproduction, 1999, Volume: 28, Issue:7

    Topics: Female; Humans; Leiomyoma; Medroxyprogesterone Acetate; Progestins; Uterine Neoplasms

1999
Goserelin (Zoladex) in the treatment of fibroids.
    British journal of obstetrics and gynaecology, 1992, Volume: 99 Suppl 7

    Topics: Buserelin; Combined Modality Therapy; Drug Therapy, Combination; Female; Goserelin; Humans; Leiomyoma; Medroxyprogesterone; Medroxyprogesterone Acetate; Receptors, Estradiol; Tamoxifen; Uterine Neoplasms

1992

Trials

14 trial(s) available for medroxyprogesterone acetate and Fibroid

ArticleYear
[Medical treatment of the uterine miomas in perimenopausal patients].
    Ginecologia y obstetricia de Mexico, 2015, Volume: 83, Issue:1

    Topics: Antineoplastic Agents, Hormonal; Female; Humans; Hysterectomy; Leiomyoma; Longitudinal Studies; Medroxyprogesterone Acetate; Middle Aged; Perimenopause; Prospective Studies; Treatment Outcome; Uterine Neoplasms

2015
Effect of steroid add-back therapy on the proliferative activity of uterine leiomyoma cells under gonadotropin-releasing hormone agonist therapy.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2005, Volume: 20, Issue:2

    Topics: Adult; Antineoplastic Agents, Hormonal; Cell Proliferation; Drug Administration Schedule; Estrogens, Conjugated (USP); Female; Gonadotropin-Releasing Hormone; Humans; Hysterectomy; Leiomyoma; Leuprolide; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Recurrence, Local; Postoperative Period; Treatment Outcome; Uterine Neoplasms

2005
Sustained benefits of leuprolide acetate with or without subsequent medroxyprogesterone acetate in the nonsurgical management of leiomyomata uteri.
    Fertility and sterility, 1995, Volume: 64, Issue:2

    Topics: Adult; Double-Blind Method; Female; Humans; Leiomyoma; Leuprolide; Medroxyprogesterone Acetate; Middle Aged; Uterine Neoplasms

1995
GnRHa and steroid add-back therapy for uterine myoma.
    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 1995, Volume: 48, Issue:2

    Topics: Administration, Oral; Adult; Antineoplastic Combined Chemotherapy Protocols; Buserelin; Drug Therapy, Combination; Estrogens, Conjugated (USP); Female; Humans; Leiomyoma; Medroxyprogesterone Acetate; Middle Aged; Time Factors; Uterine Neoplasms

1995
An evaluation of the effect of gonadotropin-releasing hormone analogs and medroxyprogesterone acetate on uterine leiomyomata volume by magnetic resonance imaging: a prospective, randomized, double blind, placebo-controlled, crossover trial.
    The Journal of clinical endocrinology and metabolism, 1993, Volume: 76, Issue:5

    Topics: Adult; Double-Blind Method; Estradiol; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Leiomyoma; Luteinizing Hormone; Magnetic Resonance Imaging; Medroxyprogesterone Acetate; Middle Aged; Placebos; Prospective Studies; Triptorelin Pamoate; Uterine Neoplasms

1993
The effects of hormone replacement therapy on uterine fibroids in postmenopausal women.
    Fertility and sterility, 1996, Volume: 65, Issue:2

    Topics: Antineoplastic Agents, Hormonal; Estradiol; Estrogen Replacement Therapy; Female; Humans; Leiomyoma; Medroxyprogesterone Acetate; Postmenopause; Uterine Neoplasms

1996
Uterine findings by transvaginal sonography during percutaneous estrogen treatment in postmenopausal women.
    Maturitas, 1996, Volume: 23, Issue:3

    Topics: Case-Control Studies; Drug Administration Schedule; Endometrium; Estradiol; Estrogen Replacement Therapy; Female; Humans; Leiomyoma; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Time Factors; Ultrasonography; Uterine Neoplasms; Uterus

1996
Medroxyprogesterone acetate with Zoladex for long-term treatment of fibroids: effects on bone density and patient acceptability.
    Human reproduction (Oxford, England), 1997, Volume: 12, Issue:3

    Topics: Adult; Amino Acids; Antigens, Tumor-Associated, Carbohydrate; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Bone Density; Female; Goserelin; Humans; Leiomyoma; Medroxyprogesterone Acetate; Middle Aged; Uterine Neoplasms; Uterus

1997
Bleeding patterns in recent postmenopausal outpatients with uterine myomas: comparison between two regimens of HRT.
    Maturitas, 1998, Jun-17, Volume: 29, Issue:3

    Topics: Anabolic Agents; Estrogens, Conjugated (USP); Female; Hormone Replacement Therapy; Humans; Leiomyoma; Medroxyprogesterone Acetate; Menopause; Menstrual Cycle; Middle Aged; Norpregnenes; Prospective Studies; Uterine Neoplasms

1998
[The effects of menopausal replacement therapy in women with uterine myomas].
    Minerva ginecologica, 1999, Volume: 51, Issue:11

    Topics: Antineoplastic Agents, Hormonal; Estradiol; Estrogen Replacement Therapy; Female; Humans; Leiomyoma; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norpregnenes; Time Factors; Uterine Neoplasms

1999
Uterine myoma in postmenopause: a comparison between two therapeutic schedules of HRT.
    Maturitas, 2000, Nov-30, Volume: 37, Issue:1

    Topics: Administration, Cutaneous; Administration, Oral; Cyproterone Acetate; Drug Administration Schedule; Estradiol; Female; Hormone Replacement Therapy; Humans; Leiomyoma; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Prospective Studies; Ultrasonography; Uterine Neoplasms

2000
Effect of different doses of progestin on uterine leiomyomas in postmenopausal women.
    European journal of obstetrics, gynecology, and reproductive biology, 2002, May-10, Volume: 102, Issue:2

    Topics: Amenorrhea; Estradiol; Estrogen Replacement Therapy; Female; Humans; Leiomyoma; Medroxyprogesterone Acetate; Postmenopause; Ultrasonography; Uterine Hemorrhage; Uterine Neoplasms

2002
Sequential Gn-RH superagonist and medroxyprogesterone acetate treatment of uterine leiomyomata.
    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 1990, Volume: 33, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Buserelin; Delayed-Action Preparations; Female; Humans; Leiomyoma; Medroxyprogesterone; Medroxyprogesterone Acetate; Time Factors; Ultrasonography; Uterine Neoplasms

1990
A randomized, double-blind trial of a gonadotropin releasing-hormone agonist (leuprolide) with or without medroxyprogesterone acetate in the treatment of leiomyomata uteri.
    Fertility and sterility, 1988, Volume: 49, Issue:3

    Topics: Adult; Antineoplastic Agents; Cholesterol; Double-Blind Method; Drug Therapy, Combination; Female; Gonadotropin-Releasing Hormone; Humans; Leiomyoma; Leuprolide; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Random Allocation; Uterine Neoplasms

1988

Other Studies

21 other study(ies) available for medroxyprogesterone acetate and Fibroid

ArticleYear
Depot Medroxyprogesterone Acetate Use and the Development and Progression of Uterine Leiomyoma.
    Obstetrics and gynecology, 2022, 05-01, Volume: 139, Issue:5

    Topics: Cohort Studies; Contraceptive Agents, Female; Delayed-Action Preparations; Female; Humans; Incidence; Leiomyoma; Medroxyprogesterone; Medroxyprogesterone Acetate

2022
Adlay (
    Molecules (Basel, Switzerland), 2019, Apr-19, Volume: 24, Issue:8

    Topics: Animals; Cell Line, Tumor; Cell Proliferation; Coix; Diethylstilbestrol; Female; Humans; Leiomyoma; Medroxyprogesterone Acetate; Mice; Phosphorylation; Plant Extracts; Rats; Uterine Neoplasms

2019
Use of depot medroxyprogesterone acetate and prevalent leiomyoma in young African American women.
    Human reproduction (Oxford, England), 2015, Volume: 30, Issue:6

    Topics: Adult; Black or African American; Cohort Studies; Confidence Intervals; Cross-Sectional Studies; Delayed-Action Preparations; Female; Humans; Leiomyoma; Medroxyprogesterone Acetate; Odds Ratio; Prevalence; Protective Agents; Ultrasonography; Uterine Diseases

2015
Gonadotropin-releasing hormone analogues inhibit leiomyoma extracellular matrix despite presence of gonadal hormones.
    Fertility and sterility, 2016, Volume: 105, Issue:1

    Topics: Antineoplastic Agents, Hormonal; Cell Culture Techniques; Cell Line, Tumor; Collagen Type I; Estradiol; Extracellular Matrix; Female; Fibronectins; Gonadotropin-Releasing Hormone; Humans; Leiomyoma; Leuprolide; Medroxyprogesterone Acetate; Time Factors; Uterine Neoplasms; Versicans

2016
Radical surgical cytoreduction of progressive leiomyomatosis peritonealis disseminata: a case report.
    The Journal of reproductive medicine, 2009, Volume: 54, Issue:7

    Topics: Adult; Disease Progression; Dose-Response Relationship, Drug; Female; Humans; Leiomyoma; Leiomyomatosis; Medroxyprogesterone Acetate; Peritoneal Cavity; Peritoneal Neoplasms

2009
Short-term change in growth of uterine leiomyoma: tumor growth spurts.
    Fertility and sterility, 2011, Volume: 95, Issue:1

    Topics: Adult; Black People; Cell Division; Disease Progression; Estrogens, Conjugated (USP); Female; Humans; Leiomyoma; Magnetic Resonance Imaging; Medroxyprogesterone Acetate; Middle Aged; Prevalence; Uterine Neoplasms; Uterus; White People

2011
Effects of GnRH analogues, 'add-back' steroid therapy, antiestrogen and antiprogestins on leiomyoma and myometrial smooth muscle cell growth and transforming growth factor-beta expression.
    Molecular human reproduction, 2002, Volume: 8, Issue:12

    Topics: Estradiol; Estrogen Receptor Modulators; Female; Gonadotropin-Releasing Hormone; Gonanes; Humans; Leiomyoma; Leuprolide; Medroxyprogesterone Acetate; Mifepristone; Muscle Development; Myocytes, Smooth Muscle; Myometrium; Oligopeptides; Progestins; Steroids; Transforming Growth Factors

2002
Depo medroxyprogesterone acetate (DMPA) therapy for uterine myomata prior to surgery.
    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2004, Volume: 85, Issue:2

    Topics: Adult; Antineoplastic Agents, Hormonal; Dose-Response Relationship, Drug; Female; Hemoglobins; Humans; Leiomyoma; Medroxyprogesterone Acetate; Menorrhagia; Middle Aged; Preoperative Care; Retrospective Studies; Uterine Neoplasms

2004
Medical management of uterine fibroids with medroxyprogesterone acetate (Depo Provera): a pilot study.
    Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology, 2004, Volume: 24, Issue:7

    Topics: Adult; Female; Hemoglobins; Humans; Leiomyoma; Medroxyprogesterone Acetate; Menorrhagia; Pilot Projects; Premenopause; Treatment Outcome; Ultrasonography; Uterine Neoplasms

2004
Vulvar leiomyoma associated with estrogen/progestin therapy. A case report.
    The Journal of reproductive medicine, 1995, Volume: 40, Issue:2

    Topics: Adult; Bartholin's Glands; Estrogen Replacement Therapy; Ethinyl Estradiol; Female; Humans; Leiomyoma; Medroxyprogesterone Acetate; Vulvar Neoplasms

1995
Gene expression of epidermal growth factor in human endometrium during decidualization.
    The Journal of clinical endocrinology and metabolism, 1994, Volume: 79, Issue:1

    Topics: Blotting, Northern; Decidua; DNA Probes; Endometrium; Epidermal Growth Factor; Female; Gene Expression; Humans; In Situ Hybridization; Leiomyoma; Medroxyprogesterone Acetate; Pregnancy; Protein Precursors; RNA, Messenger; Uterine Neoplasms

1994
Expression of connexin-43 in human myometrium and leiomyoma.
    American journal of obstetrics and gynecology, 1993, Volume: 169, Issue:5

    Topics: Adult; Cells, Cultured; Connexin 43; Estradiol; Female; Gap Junctions; Humans; Leiomyoma; Medroxyprogesterone Acetate; Middle Aged; Muscle, Smooth; Myometrium; RNA, Messenger; Uterine Neoplasms

1993
Uterine fibroids: protocols of integrated medical/surgical treatment.
    Clinical and experimental obstetrics & gynecology, 1993, Volume: 20, Issue:3

    Topics: Abortion, Habitual; Biopsy; Combined Modality Therapy; Estrogens, Conjugated (USP); Female; Fertility; Gonadotropin-Releasing Hormone; Humans; Hysterectomy; Infertility, Female; Leiomyoma; Medroxyprogesterone Acetate; Menopause; Pregnancy; Uterine Neoplasms; Uterus

1993
Response of "benign" metastasizing leiomyoma to progestin withdrawal. Case report.
    European journal of gynaecological oncology, 1993, Volume: 14, Issue:1

    Topics: Female; Humans; Leiomyoma; Lung Neoplasms; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Middle Aged; Neoplasms, Hormone-Dependent; Progesterone Congeners; Uterine Neoplasms

1993
Gonadotropin-releasing hormone (GnRH) and GnRH receptor gene expression in human myometrium and leiomyomata and the direct action of GnRH analogs on myometrial smooth muscle cells and interaction with ovarian steroids in vitro.
    The Journal of clinical endocrinology and metabolism, 1996, Volume: 81, Issue:9

    Topics: Adult; Amino Acid Sequence; Base Sequence; Cell Division; DNA; Estradiol; Female; Gene Expression; Gonadotropin-Releasing Hormone; Humans; Leiomyoma; Leuprolide; Medroxyprogesterone Acetate; Molecular Sequence Data; Muscle, Smooth; Myometrium; Receptors, LHRH; Transforming Growth Factor beta; Uterine Neoplasms

1996
Protective effect of depot-medroxyprogesterone acetate on surgically treated uterine leiomyomas: a multicentre case-control study.
    British journal of obstetrics and gynaecology, 1997, Volume: 104, Issue:6

    Topics: Bone Density; Chemotherapy, Adjuvant; Delayed-Action Preparations; Drug Monitoring; Female; Humans; Leiomyoma; Medroxyprogesterone Acetate; Progesterone Congeners; Uterine Neoplasms

1997
[Intrauterine pregnancy with uterine myoma after downregulation with GnRH analogs].
    Geburtshilfe und Frauenheilkunde, 1992, Volume: 52, Issue:2

    Topics: Adult; Antineoplastic Agents; Buserelin; Delayed-Action Preparations; Dose-Response Relationship, Drug; Down-Regulation; Drug Administration Schedule; Female; Goserelin; Humans; Leiomyoma; Medroxyprogesterone; Medroxyprogesterone Acetate; Pregnancy; Pregnancy Complications, Neoplastic; Receptors, LHRH; Uterine Neoplasms

1992
Maintained reduction of uterine leiomyoma following addition of hormonal replacement therapy to a monthly luteinizing hormone-releasing hormone agonist implant: a pilot study.
    Human reproduction (Oxford, England), 1991, Volume: 6, Issue:4

    Topics: Adult; Antineoplastic Agents; Bone Density; Buserelin; Cholesterol; Contraceptive Agents, Female; Drug Therapy, Combination; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Goserelin; Humans; Leiomyoma; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation; Middle Aged; Pilot Projects; Triglycerides; Uterine Neoplasms

1991
Treatment of abnormal uterine bleeding with the gynecologic resectoscope.
    The Journal of reproductive medicine, 1991, Volume: 36, Issue:10

    Topics: Adult; Aged; Amenorrhea; Antineoplastic Agents; Catheterization; Danazol; Electrocoagulation; Endometrium; Female; Humans; Hysteroscopes; Leiomyoma; Leuprolide; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation Disturbances; Middle Aged; Uterine Neoplasms; Uterus

1991
Gonadotropin-releasing hormone agonists and estrogen-progestogen replacement therapy.
    American journal of obstetrics and gynecology, 1990, Volume: 162, Issue:2

    Topics: Drug Therapy, Combination; Endometriosis; Estrogen Replacement Therapy; Female; Gonadotropin-Releasing Hormone; Humans; Leiomyoma; Leuprolide; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Uterine Neoplasms

1990
Treatment of leiomyomata uteri with short-term leuprolide followed by leuprolide plus estrogen-progestin hormone replacement therapy for 2 years: a pilot study.
    Fertility and sterility, 1989, Volume: 51, Issue:3

    Topics: Bone and Bones; Climacteric; Drug Administration Schedule; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Gonadotropin-Releasing Hormone; Humans; Leiomyoma; Leuprolide; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Pilot Projects; Ultrasonography; Uterine Neoplasms; Uterus

1989